Catalyst Wire Dossier Catalyst Wire Dossier

Vertebral bone marrow-derived mesenchymal stem cells (BM-MSC)

· Mayo Clinic
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vertebral bone marrow-derived mesenchymal stem cells (BM-MSC), covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)

See pricing